Procter & Gamble is set to report Q1 fiscal 2027 results on October 22, with sales projected to rise 1.4% to $22.7B but EPS expected to decline 5%. Higher input costs and inflation are pressuring gross margins, projected to contract 120 basis points. While the company benefits from innovation and pricing strategies, valuation concerns persist with a forward P/E of 22.02X, above industry averages.

Procter & Gamble is expected to report Q1 earnings of $1.89 per share, representing a 5% year-over-year decline, with revenues projected at $22.7 billion (up 1.4%). The company has a negative Earnings ESP of -0.46% and Zacks Rank #3, making it difficult to predict an earnings beat. However, P&G has beaten consensus estimates in all four of the last quarters.

Margin debt has surged 49% year-over-year, a warning signal that has preceded market declines 83% of the time since 1960. In response, the author is adopting a defensive investment strategy focused on high-quality dividend growth stocks, particularly through the Schwab U.S. Dividend Equity ETF and individual positions like Procter & Gamble, while building cash reserves for potential market opportunities.

With concerns about a potential bear market, the article recommends the Schwab U.S. Dividend Equity ETF (SCHD) as a defensive investment strategy. Based on 2022 bear market performance, defensive sectors like healthcare, consumer staples, and energy outperformed tech-heavy indexes. SCHD holds 102 stocks with minimal tech exposure (9.23%) and heavy weighting in defensive sectors, making it suitable for portfolio protection during economic downturns.

Procter & Gamble stock closed at $153.20, up 1.3% and outperforming the broader market decline. The company is scheduled to report earnings on October 22, 2026, with projected EPS of $1.89 (down 5.03% YoY) and quarterly revenue of $22.7 billion (up 1.39% YoY). PG currently holds a Zacks Rank of #3 (Hold) with a Forward P/E of 21.66, trading at a premium to its industry average.

Procter & Gamble has recently attracted investor attention with shares returning +4.1% over the past month, outperforming the S&P 500's +2.4% gain. The company maintains a Zacks Rank #3 (Hold) rating with modest earnings growth expectations of +1.3% for the current fiscal year and +6.2% for the next year. However, P&G is trading at a premium valuation (Grade D) compared to peers, suggesting it may perform in line with the broader market in the near term.

The article recommends four consumer staples companies as long-term dividend investments: Procter & Gamble, Coca-Cola, Colgate-Palmolive, and Hershey. All four have decades of consistent dividend payments, strong brand portfolios, and generate sufficient free cash flow to sustain and grow their dividends through economic cycles.

Zacks Research Daily features analysis of 16 major stocks on October 8, 2026. Eli Lilly benefits from strong GLP-1 drug demand with positive momentum, Procter & Gamble shows modest growth supported by strong brands and innovation, and Shell demonstrates solid execution and cash generation. Additional coverage includes microcap stocks PrimeEnergy and Aeries Technology, plus analysis of HPE, Jabil, and other companies across various sectors.

Procter & Gamble (PG) closed at $148.41, outperforming the S&P 500 on the day but underperforming over the past month. The company holds a Zacks Rank #3 (Hold) rating with expected Q3 EPS declining 5.03% year-over-year, though full-year earnings are projected to grow 1.31%. PG trades at a premium valuation with a Forward P/E of 20.9 versus its industry average of 19.41, and its PEG ratio of 3.62 exceeds the industry average of 2.46.

The article recommends three dividend stocks with strong track records of never cutting payouts: Realty Income (O) with a 6% yield and 56+ years of consecutive monthly dividends, Coca-Cola (KO) with 64 years of consecutive dividend increases and recent strong market performance, and Procter & Gamble (PG) with 70 years of dividend raises and a 3% yield. These stocks are positioned as defensive investments suitable for potential market corrections.

Procter & Gamble stock has fallen 18.5% from its all-time high, pushing its dividend yield to 3% and valuation to 22x forward earnings. While the company faces near-term headwinds including inflation, higher input costs, and market share erosion, its strong cash flow generation, 70-year dividend growth history, and cost-reduction strategy suggest it could represent a buying opportunity if management can execute its turnaround plan.

The S&P 500 Shiller CAPE ratio has reached historically high levels only twice in 155 years, with the previous instance preceding the dot-com crash. While a market decline may be coming, Johnson & Johnson, Procter & Gamble, and Enterprise Products Partners are positioned to weather potential downturns due to their stable cash flows, dividend histories, and defensive business models.